Sirolimus protein-bound Alternatives Compared
Sirolimus protein-bound | Fyarro |
|
---|
Sirolimus protein-bound | Fyarro (sirolimus protein-bound) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. sirolimus protein-bound may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. Fyarro may also be used for purposes not listed in this medication guide. |
||||||||
More about Sirolimus protein-bound | More about Fyarro (sirolimus protein-bound) | ||||||||
Ratings & Reviews | |||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: sirolimus protein-bound side effects in more detail. |
See also: Fyarro side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Fyarro prices |
||||||||
Dosage Form(s) Available | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Fyarro |
N/A |
||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
59 hours |
59 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 367 drugs are known to interact with sirolimus protein-bound:
|
A total of 367 drugs are known to interact with Fyarro:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.